North America
North America is one of the leading markets for molecular diagnostics, driven by advanced healthcare infrastructure, significant investments in research and development, and widespread adoption of molecular diagnostic technologies. The high prevalence of chronic diseases such as cancer, infectious diseases, and genetic disorders has contributed to the demand for early and accurate...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian